Nvidia: The danger of the irreplaceable CEO
Could your company survive its founder? In light of the Nvidia scandal, Jim Pulcrano joins Tim Quigley on CEO succession, board accountability and the danger of irreplaceable leaders....
Podcasts
Biotech
How AI is taking the Biotech industry by storm
April 5, 2024 • by Michael R. Wade, Amit Joshi in Podcasts • 
Podcast available
Mike & Amit discuss how artificial intelligence may revolutionize healthcare, and improve our collective quality of life...
Apple Google SpotifyThere have been incredible advances in biotech over the last decade, and today, technology is ever-present in life sciences.
Digital tools like AI and machine learning are increasingly used in the development of pharmaceuticals, while physical products like CRISPR are allowing us to edit the very building blocks of life. As Amit Joshi says, we now have “Photoshop for DNA.”
But are these advances getting the attention they deserve?
Mike and Amit argue that in recent years, biotech has been overshadowed by the rise of AI assistants, NFTs, and cryptocurrency.
To balance the scales, this week our IMD professors discuss how artificial intelligence may revolutionize healthcare, and how new technologies may improve our collective quality of life.
Authors
Listen to our new series
Trump lost congress. What changes for global business?
After the US midterms, what changes for global business? IMD President David Bach on trade, AI, uncertainty, and the new rules of leadership....
The youth backlash: Can business afford to ignore it?
Young people are losing faith in the future. IMD's Vanina Farber explains why business leaders must rethink their role – and act before it's too late....
AI is everywhere – where are the profits?
Companies are spending billions on artificial intelligence. But are they making any money from it? IMD's Karl Schmedders on hidden costs, vibe coding and how companies can turn AI into business value....